Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation

Journal of Allergy and Clinical Immunology

Volumn 102, Issue 5, 1998, Pages 783-788

  Hoshino, Makoto ^a   Nakamura, Yutaka ^a   Sim, JaeJoon ^a   Shimojo, Jun ^a   Isogai, Sho ^a  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Collagen; Inflammation; Matrix metalloproteinase; Remodeling; Tenascin; Tissue inhibitors of metalloproteinase

Indexed keywords

GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; BRONCHUS MUCOSA; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FIBROSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUBMUCOSA;

EID: 0031753315     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(98)70018-1     Document Type: Article

References (33)

1. Laitinen LA, Heino M, Laitinen A, Kava T, Haahtela T. Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am Rev Respir Dis 1985;131:599-606.
2. Kay AB. Asthma and inflammation. J Allergy Clin Immunol 1991;87: 893-910.
3. Bousquet J, Chanez P, Lacoste JY, Barneon G, Ghavanian N, Enander I, et al. Eosinophilic inflammation in asthma. N Engl J Med 1993;323: 1033-9.
4. Merker H-J. Morphology of the basement membrane. Microsc Res Techniq 1994;28:95-124.
5. Roche WR, Beasley R, Williams J, Holgate ST. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1989; 1:520-4.
6. Erickson HP. Tenascin-C, tenascin-R, and tenascin-X: a family of talented proteins in search of functions. Curr Opin Cell Biol 1993;5:869-76.
7. Ehrisman R, Mackie EJ, Pearson CA, Sakakura T. Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell 1986;47:131-9.
8. Laitinen A, Altraja A, Kampe M, Linden M, Virtanen I, Laitinen LA. Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid. Am J Respir Crit Care Med 1997; 156:951-8.
9. Raghow R. The role of extracellular matrix in postinflammatory wound healing and fibrosis. FASE J 1994;8:823-31.
10. Mackie EL, Halfter W, Liverani D. Induction of tenascin in healing wounds. J Cell Biol 1988;107:2757-67.
11. Emonard H, Grimaud J-A. Matrix metalloproteinases: a review. Cell Mol Biol 1990;36:131-53.
12. Murphy G, Docherty AJP. The matrix metalloproteinases and their inhibitors. Am J Respir Cell Mol Biol 1992;7:120-5.
13. O'Connor CM, FitzGerald MX. Matrix metalloproteases and lung disease. Thorax 1994;49:602-9.
14. Murphy G, McAlpine CG, Poll CT, Reynolds JJ. Purification and characterization of a bone metalloproteinase that degrades gelatin and types IV and V collagen. Biochem Biophys Acta 1985;831:49-58.
15. Martrisian LM. Metalloproteinases and their inhibitors in matrix remodelling. Trends Genet 1990;6:121-5.
16. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987;136:225-44.
17. Takishima T, Hida W, Sasaki H, Suzuki S, Sasaki T. Direct-writing recorder of the dose-response curves of the airway to methacholine. Chest 1981;80:600-6.
18. Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, Macdonald S, et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP Complexes). J Histochem Cytochem 1984;32:219-29.
19. Howeedy AA, Virtanen I, Laitinen L, Gould NS, Koukoulis GK, Gould VE. Differential distribution of tenascin in the normal, hyperplastic, and neoplastic breast. Lab Invest 1990;63:798-806.
20. Zucker S, Lysik RM, Zarrabi MH, Moll U. Mr 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer. Cancer Res 1993;53:140-6.
21. Kodama S, Kishi J, Obata K, Iwata K, Hayakawa T. Monoclonal antibodies to bovine collagenase inhibitor. Collagen Rel Res 1987;7:341-50.
22. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10.
23. Weinacker A, Ferrando R, Elliott M, Hogg J, Balmes J, Sheppard D. Distribution of integrins αvβ6 and α9β1 and their known ligands, fibronectin and tenascin, in human airways. Am J Respir Cell Mol Biol 1995;12:547-57.
24. Brewster CEP, Howarth PH, Djukanovic R, Wilson J, Holgate ST, Roche WR. Myofibroblasts and subepithelial fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 1990;3:507-11.
25. Dean DD, Martel-Pelletier J, Pelletier J-P, Howell DS, Woessner JF Jr. Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest 1989;84:678-85.
26. Delacourt C, Le Bourgeois ML, d'Ortho M-P, Doit C, Scheinmann P, Navarro J, et al. Imbalance between 95 kDa type IV collagenase and tissue inhibitor of metalloproteinases in sputum of patients with cystic fibrosis. Am J Respir Crit Care Med 1995;152:765-74.
27. Ohno I, Ohtani H, Nitta Y, Suzuki J, Hoshi H, Honma M, et al. Eosinophils as a source of matrix metalloproteinase-9 in asthmatic airway inflammation. Am J Respir Cell Mol Biol 1997;16:212-9.
28. Mautino G, Oliver N, Chanez P, Bousquet J, Capony F Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics. Am J Respir Cell Mol Biol 1997;17:583-91.
29. Djukanovic R, Lai CKW, Wilson JW, Britten KM, Wilson SJ, Roche WR, et al. Bronchial mucosal manifestations of atopy: a comparison of markers of inflammation between atopic asthmatics, atopic nonasthmatics and healthy controls. Eur Respir J 1992;5:538-44.
30. Chetta A, Foresi A, Donno MD, Consigli GF, Bertorelli G, Pesci A, et al. Bronchial responsiveness to distilled water and methacholine and its relationship to inflammation and remodeling of the airways in asthma. Am J Respir Crit Care Med 1996;153:910-7.
31. Boulet L-P, Laviolette M, Turcotte H, Cartier MA, Dugas M, Malo J-L, et al. Bronchial subepithelial fibrosis correlates with airway responsiveness to methacholine. Chest 1997;112:45-52.
32. Lambert RK. Role of bronchial basement membrane in airway collapse. J Appl Physiol 1991;71:666-73.
33. Wiggs BR, Bosken C, Pare PD, James A, Hogg JC. A model of airway narrowing in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis 1992;145:1251-8.